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INTRODUCTION
Hepatitis C virus (HCV) has become an important
cause of chronic liver disease and liver cell cancer
world wide . It has world wide prevalence of 3.1%
withAfrica recording the highest prevalence of 5.3%
. It is estimated that about 170 million people world
wide are chronically infected with HCV and
majority are in the developing countries . HCV has
been found to lead to chronicity in 70 - 85% of cases.
About 30% of those infected will progress to liver
cirrhosis and ultimately to end stage liver failure and
hepatic carcinoma . The mode of transmission of the
virus is mainly parenteral. Some risk factors
associated with HCV infections are transfusion of
blood or blood products, tattooing /scarification with
re-use of instruments, body piercing, injection/illict
drug use, multiple homosexual and heterosexual
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body fluids . Sickle Cell anaemia (SCA) is a common
cause of morbidity and mortality in Nigeria with a
prevalence rate of 1.6 3% . It is a genetic disorder
with life long complications. The natural course of
SCA involves series of thrombotic crises with
therapeutic interventions within and outside hospital
settings. Common medical interventions for SCA
patients in Nigeria include blood transfusion,
injections (often by unqualified persons),
scarifications, tattooing and ritual marks by
herbalists. These predispose them to risk of HCV
infection. Some studies have suggested that blood
transfusion increases the risk of HCV infection in
patients with SCA . De Vault assayed 121
consecutive SCA patients in the United States of
America (USA) for HCV antibodies and found 25
(20.7%) to be anti-HCV positive. This suggests a
relatively high prevalence of HCV infection in SCA
patients in the USA. Few local studies exist in
Nigeria on HCV. To our knowledge, no study has been
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The hepatitis C Virus (HCV) has become an important cause of chronic liver disease and liver
cancer worldwide. Blood transfusion is one of the important modes of transmission. There is need to study the
prevalence among those at risk such as sickle cell anaemia (SCA) patients. Such information will broaden
knowledge of the problem among SCApatients transfused with blood in this part of the country
To determine the prevalence of HCV antibodies among children with SCAtransfused with blood in
Enugu, compared with their non transfused counterparts as well as the roles of blood transfusion and
traditional surgery in the prevalence of HCV infection.
The study was conducted among 269 children with SCA attending the paediatrics sickle cell
clinic at University of Nigeria Teaching Hospital (UNTH) Enugu, with 136 transfused SCApatients as subjects
and 133 age and sex matched non-transfused SCAwho served as controls.
The results showed an HCV antibody prevalence of 6.6% among the transfused and 5.3% among the
non-transfused (controls) SCA patients (P=0.610). There was positive association between number of
transfusions and HCV seropositiviy, such that those who had received 4 or more units of blood had a prevalence
rate of more than 50% (P = 0.001). The influence of scarifications on the prevalence of antibodies to HCV
(antiHCV) for the non transfused (controls) was statistically significant (P= 0.001).
HCV infection is not uncommon in children with SCA. The prevalence of HCV infection in
transfused SCApatients is not significantly higher than their age/sex matched controls.
Blood transfusion, Hepatitis C, Sickle cell anaemia. (Accepted 11 August 2008)
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Nigeria. This study was undertaken to look at HCV
in SCA patients. Information from this study may
give a clearer picture of the burden of HCV amongst
children with SCA in South Eastern Nigeria. It is
hoped that information from this work may influence
blood banking policies and form a basis for health
education of communities. Finally the results of the
study will advance knowledge on HCV infection in
Nigeria SCApatients and may form a basis for future
research.
This study was done at University Nigeria Teaching
Hospital (UNTH) Enugu, which is a referral tertiary
health institution and serves mainly the South
Eastern States of Nigeria. It is a 700 - bed capacity
hospital. It runs two well established sickle cell
clinics which cater for paediatric and adult patients
respectively. Approval was obtained from UNTH
ethical committee before commencement of this
study. Informed written consent was obtained from
each parent/guardian and the older children were
applicable. Questionnaires were used to collect data
on age and sex of subjects, occupation and
educational level of the parents, risk factors for HCV
infection like blood transfusion and traditional
surgery (tattooing, scarification or ritual marks).
The social class was determined using classification
of social class proposed by Oyedeji . The subjects
were SCA patients, who had been transfused with
blood. SCA patients, who had not been transfused
with blood, and matched for age and sex served as
controls.
The inclusion criteria were:
(a) SCA patients aged 1 to 18 years (completed
age) with genotype confi rmed by
Hemoglobin electrophoresis.
(b) Patients who were transfused at least 3
months before collection of blood sample
After informed consent, patients (subjects and
controls) were recruited consecutively from the
sickle clinic of UNTH from February to September
2005. Blood samples were obtained under aseptic
condition for HCV antibody assay. The blood
samples were centrifuged within 3 hours of
collection and the serum obtained was immediately
assayed for HCV antibodies with new (Second)
generation HCV one step hepatitis C Virus test strip
(serum / Plasma from Acumen diagnostic Inc. USA)
which is a rapid chromatographic enzyme immuno
assay for the qualitative detection of antibody to
hepatitis C virus in serum or plasma . The sensitivity
of the test strip is > 99%, while its specificity is
98.6% . Parents and guardians whose children tested
positive were counseled on the nature of HCV







Data analysis was done with statistical package for
social science (SPSS) version 11.5 software. A P-
value of < 0.05 was considered statistically
significant.
Of a total of 328 questionnaire forms distributed, 301
responded giving a response rate of 91.8%.The other
27 declined consent. Of the 301 that responded, 4
could not be matched for age and sex. Nineteen
questionnaires were rejected due to incomplete data
and 9 patients declined blood letting. Ultimately 269
children with SCA aged 1 to 18 years were studied
made up of 136 subjects and 133 controls. The mean
age for the subjects and controls were 10.19 5.31
years and 10.11 3.11 years respectively.
Table 1 shows the age group of the study population.
Majority of the study population were between 13 18
years accounting for 36.8% of the subjects and
37.6% of controls.
Table 2 depicts social class of the subjects and
controls. Majority of the subjects and controls were in
lower socio economic groups (class IV V). This
comprised of 60.29% of the subject and 60.9% of the
controls. There were 30.15% of the subjects and
27.8% of controls in social class III, while 9.56% of
subjects and 11.3% of controls respectively were in
high social class (class I II). The socio economic
spread of subjects compared to the controls showed
no statistically significant difference P= 0.810.
Table 3 compares the distribution of Anti-HCV
seropositivity in subjects and controls. Out of 136
subjects, 9 tested positive, giving a prevalence rate of
6.6%. In the control population, 7 out of 133 tested
positive, giving a prevalence rate of 5.3%. The
difference in prevalence rates of the subjects
compared to the controls was not statistically
significant, P= 0.610.
Table 4 shows the frequency of blood transfusion in
relation to HCV seropositivity among the subjects.
The number of blood transfusions ranged from 1 8
units with a mean of 1.95 ± 1.44 per subject. Among
those that tested positive, the highest rate was
recorded in those that received 4 or more units of
blood transfusions. This may suggest that the
chances of being positive increases with increasing
units of blood transfusion. When different units of
blood transfusion were compared the difference was
statistically significant P= 0.001.
Table 5 highlights the effect of scarification on anti
HCV seropostitivity among the subjects and controls.
Among the 37 SCA subjects that had scarification, 4
(10.8%) tested positive. While out of 99 without
scarification, 5(5.1%) tested positive. When those
with and without scarification were compared the
difference was not statistically significant P>0.05.
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DISCUSSION
This study showed a prevalence rate of 6.6% of HCV
antibodies among blood transfused children with
SCAin Enugu. The control group showed prevalence
of 5.3% though, the difference was not statistically
significant, (P = 0.610). A prevalence rate of 6.6% of
HCV antibodies is within the range of 5 10% reported
from Lagos (5%) , Ilorin (5%) and USA (10%) in
transfused patients with SCA. However, this rate is
lower than the value reported from Benin (20%
prevalence rate). The high figure in the Benin study
was explained by the cross reactivity with Eschericha
coli and also the fact that first generation kits were
used. The prevalence rates of transfused and non
transfused SCA patients in this study are very close.
This may not be surprising, considering that the
prevalence in the general population is 8%, , which is
higher than the values obtained from this study. This
may suggest that there may be other important routes
of transmission apart from blood transfusion.
There was a statistically significant trend between the
prevalence of anti-HCV antibodies and increasing
number of blood transfusion among transfused SCA
patients. This is similar to the trend observed in
Benin , Lagos . Similar trend was also observed in
America However, the magnitude of the increase
appears to be higher in this study as more than 50% of
those who received 4 or more units of blood in this
study were anti-HCV positive. This is comparatively
higher than those that received more than 10units of
blood in all American studies reviewed with
seropositivity of 30%, 23% and 26.4% . This is
not surprising considering that blood is not routinely
screened for HCV antibodies. It is therefore
important that blood be given only when necessary
and transfused blood be screened for HCV antibodies.
Scarifications did not significantly increase the risk of
acquiring HCV infection in the subjects. This is
because 5 of the 9 children that tested positive for
anti-HCV had no history of scarification or ritual
marks as against 4 that had history of scarification and
ritual marks, even though the difference was not
statistically significant. This agrees with finding in
Lagos where there is not significant difference
between those that had and those that had no










However among the control population, 31 patients
had scarifications, out of which 7 (22.6%) tested
positive. while out of the 102 without scarification
none (0%) tested positive. When those with and
without scarification in the controls were compared,
the difference was statistically significant P = 0.001.
The scarifications were all done by traditional







:Age Group of the Subjects and Controls.
Social Class of the Subjects and Controls.
Prevalence of Anti-HCV Antibodies in
Subjects and Controls.
Frequency Distribution of Blood
Transfusion in Relation to Anti HCV
Seropositivity among Subjects.
Age group Total Subjects Controls
Total
Social Class Total Subjects Controls
Total
Total No (%) No (%)
Group No (%) Positive Prevalence Negative
(Years) No (%) No (%) No (%)
1 - 6 76 (28.25) 39 (28.69) 37 (27.82)
7 - 12 93 (34.57) 47 (34.51) 46 (34.59)
3 - 18 100 (37.18) 50 (36.80) 50 (37.59)
269 (100.00) 136 (100.00) 133 (100.00)
No (%) No (%) No (%)
I 8 (2.97) 4 (2.94) 4 (3.0)
II 20 (7.44) 9 (6.62) 11 (8.3)
Middle III 78 (29.00) 41 (30.15) 37 (27.8)
IV 127 (47.21) 65 (47.79) 62 (46.6)
V 36 (13.38) 17 (12.50) 19 (14.3)
269 (100.00) 136 (100.00) 133 (100.00)
Subjects 136 (100) 9 (6.6) 127 (93.4)
Controls 133 (100) 7 (5.3) 126 (94.7)
X = 0.22 P = 0.610
Units of Blood Total Positive Negative
Transfusion No (%) No (%) No (%)
1 76 (55.9) 4 (44.4) 72 (56.7)
2-3 45 (33.1) 0 45 (35.4)
4 15 (11.0) 5 (55.6) 10 (7.9)
136 9 127
P> 0.05
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Table 5: Effect of Scarifications on Subjects and Controls with Anti-HCV Seropositivity
Subjects Controls
Scarifications Total Positive Negative Total Positive Negative X = 1.45 X = 24.99
Yes 37 4(10.8%) 33(89.2%) 31 7(22.6%) 24(77.4%) P = 0.230 P = 0.001*
No 99 5(5.1%) 94(94.9%) 102 0(0%) 102(100%)
Total 136 9 127 133 7 126
* = Statistically significant (P < 0.05)
Subjects Controls
No No No No
2 2
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scarifications significantly influenced the risk of
acquisition of HCV infection. Of the 31 controls that
had scarification, all were done by traditional
healers. Since this control group was not transfused,
it is possible that they may have been infected
through this scarifications. The positive HCV
antibody seen in this non transfused sicklers may
confirm the view that this infection can be acquired
via other routes.
1. HCV infection is not uncommon in sickle cell
anaemia patients.
2. The prevalence of HCV infection in
transfused SCA patients is not significantly
higher than their age/sex matched controls.
3. Blood transfusion does not appear to be the
only route of HCV infection in SCA patients
in Enugu, as there are other yet to be fully
defined risk factors such as scarification
marks and other traditional surgical practices.
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